Anissa McCLENNY

Seasoned clinical research professional with broad therapeutic expertise spanning Oncology, CNS, Cardiovascular, and Infectious Disease. Proven track record across CRA, oversight, and program lead roles. Adept at driving trial quality, site performance, and regulatory compliance.

CRA/Senior CRA

Therapeutic experience across multiple therapeutic areas

• Monitored 40+ therapeutic areas including Oncology, CNS, Cardiovascular, Dermatology, and Respiratory across Phase I–IV trials
• Delivered site oversight and data quality management across complex indications including Alzheimer's, Epilepsy, and NASH
• Ensured GCP/ICH compliance and protocol adherence across global multi-site studies in Hepatology, Endocrinology, and Women's Health

Sponsor/CRO Oversight Lead

Sponsor and CRO oversight responsibilities across therapeutic areas

• Led CRO oversight across MACE, COVID-19 vaccine, Nephrology (ESKD), and Women's Health studies ensuring vendor accountability
• Drove sponsor–CRO alignment, risk-based monitoring strategies, and quality metrics across diverse therapeutic portfolios
• Managed escalation pathways and performance tracking for CRO-led sites across Cardiovascular and Dermatology programs

Clinical Trial Lead

Clinical trial leadership across therapeutic areas

• Led clinical trials across HIV, Breast Cancer, Otitis Media, and Stress Urinary Incontinence from startup to closeout
• Coordinated cross-functional teams to meet enrollment targets, regulatory milestones, and data integrity standards
• Oversaw site activation, investigator training, and protocol deviation management across Infectious Disease and Oncology studies

Clinical Program Lead

• Led clinical program strategy and execution for Breast Cancer indication, overseeing trial operations and stakeholder alignment

Master of Science - Organizational Management - Capella University (2011)

Bachelor of Science - Biology - Shaw University (1994)